| Overview |
| bsm-90353R |
| Annexin V Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Annexin V |
| 301-320/320 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 308 |
| P08758 |
| ANXA5; Annexin A5; CPB-I; PAP-I; Placental Anticoagulant Protein I; Vascular Anticoagulant-Alpha; Calphobindin I; Endonexin II; Annexin V; VAC-Alph; RPRGL3; ANX5; ENX2; Placental Anticoagulant Protein 4; Thromboplastin Inhibitor; Anchorin CII; Lipocortin V; VAC-Alpha; Annexin-5; PP4; Epididymis Secretory Protein Li 7; HEL-S-7; CBP-I |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz